ITGAE and neoplasm: While TGFβ also conveys negative signals toward IL-1 and IL-2-dependent proliferation of activated T cells [37,38], B cells [39], and myeloid cells [40], it appears to play a key role for CD103-dependent immunity within tumor microenvironments [32,36].